Deng J, Zhang Y, Bai R, Yu T, Zhao Y, Liu H
Prog Orthod. 2025; 26(1):2.
PMID: 39747791
PMC: 11695529.
DOI: 10.1186/s40510-024-00548-w.
Kolipaka R, Magesh I, Karthik S, Ashok Bharathy M, Saranya I, Preetha D
Exp Ther Med. 2024; 29(1):20.
PMID: 39624592
PMC: 11609762.
DOI: 10.3892/etm.2024.12770.
Amore E, Cenni V, Piazzi M, Signore M, Orlandi G, Neri S
Biomolecules. 2024; 14(10).
PMID: 39456175
PMC: 11505649.
DOI: 10.3390/biom14101243.
Shakya A, Li Y, Chang N, Liu X
Compos B Eng. 2024; 283.
PMID: 39071449
PMC: 11270636.
DOI: 10.1016/j.compositesb.2024.111673.
Siewe N, Friedman A
PLoS One. 2024; 19(5):e0303978.
PMID: 38805428
PMC: 11132490.
DOI: 10.1371/journal.pone.0303978.
Chordoma cells possess bone-dissolving activity at the bone invasion front.
Kawaai K, Oishi Y, Kuroda Y, Tamura R, Toda M, Matsuo K
Cell Oncol (Dordr). 2024; 47(5):1663-1677.
PMID: 38652222
PMC: 11466907.
DOI: 10.1007/s13402-024-00946-6.
Apigenin and Rutaecarpine reduce the burden of cellular senescence in bone marrow stromal stem cells.
Ali D, Okla M, Abuelreich S, Vishnubalaji R, Ditzel N, Hamam R
Front Endocrinol (Lausanne). 2024; 15:1360054.
PMID: 38638133
PMC: 11024792.
DOI: 10.3389/fendo.2024.1360054.
Targeting transforming growth factor beta signaling in metastatic osteosarcoma.
Ge R, Huang G
J Bone Oncol. 2023; 43:100513.
PMID: 38021074
PMC: 10666000.
DOI: 10.1016/j.jbo.2023.100513.
ASPORIN: A root of the matter in tumors and their host environment.
Lall S, Alsafwani Z, Batra S, Seshacharyulu P
Biochim Biophys Acta Rev Cancer. 2023; 1879(1):189029.
PMID: 38008263
PMC: 10872503.
DOI: 10.1016/j.bbcan.2023.189029.
The expression changes of PD-L1 and immune response mediators are related to the severity of primary bone tumors.
Eghtedari A, Vaezi M, Safari E, Salimi V, Safizadeh B, Babaheidarian P
Sci Rep. 2023; 13(1):20474.
PMID: 37993664
PMC: 10665336.
DOI: 10.1038/s41598-023-47996-8.
Epithelial-like transport of mineral distinguishes bone formation from other connective tissues.
Blair H, Larrouture Q, Tourkova I, Nelson D, Dobrowolski S, Schlesinger P
J Cell Biochem. 2023; 124(12):1889-1899.
PMID: 37991446
PMC: 10880123.
DOI: 10.1002/jcb.30494.
Bone marrow from periacetabular osteotomies as a novel source for human mesenchymal stromal cells.
Handke M, Rakow A, Singer D, Miebach L, Schulze F, Bekeschus S
Stem Cell Res Ther. 2023; 14(1):315.
PMID: 37924114
PMC: 10625289.
DOI: 10.1186/s13287-023-03552-9.
RANKTLR2 myeloid subpopulation converts autoimmune to joint destruction in rheumatoid arthritis.
Zhang W, Noller K, Crane J, Wan M, Wu X, Cahan P
Elife. 2023; 12.
PMID: 37204303
PMC: 10299822.
DOI: 10.7554/eLife.85553.
Metabolic Health and Disease: A Role of Osteokines?.
Shimonty A, Bonewald L, Huot J
Calcif Tissue Int. 2023; 113(1):21-38.
PMID: 37193929
DOI: 10.1007/s00223-023-01093-0.
Osteochondrogenesis by TGF-β3, BMP-2 and noggin growth factor combinations in an muscle tissue model: Temporal function changes affecting tissue morphogenesis.
Liu H, Muller P, Aszodi A, Klar R
Front Bioeng Biotechnol. 2023; 11:1140118.
PMID: 37008034
PMC: 10060664.
DOI: 10.3389/fbioe.2023.1140118.
Influence of the Immune Microenvironment Provided by Implanted Biomaterials on the Biological Properties of Masquelet-Induced Membranes in Rats: Metakaolin as an Alternative Spacer.
Durand M, Oger M, Nikovics K, Venant J, Guillope A, Jouve E
Biomedicines. 2022; 10(12).
PMID: 36551773
PMC: 9776074.
DOI: 10.3390/biomedicines10123017.
One-Step Preparation of an Injectable Hydrogel Scaffold System Capable of Sequential Dual-Growth Factor Release to Maximize Bone Regeneration.
Kim J, Kim Y, Song S
Adv Healthc Mater. 2022; 12(4):e2202401.
PMID: 36453668
PMC: 11468681.
DOI: 10.1002/adhm.202202401.
Irisin reduces bone fracture by facilitating osteogenesis and antagonizing TGF-β/Smad signaling in a growing mouse model of osteogenesis imperfecta.
Sun B, Wu H, Lu J, Zhang R, Shen X, Gu Y
J Orthop Translat. 2022; 38:175-189.
PMID: 36439629
PMC: 9672882.
DOI: 10.1016/j.jot.2022.10.012.
A multi-model approach to predict efficacious clinical dose for an anti-TGF-β antibody (GC2008) in the treatment of osteogenesis imperfecta.
Mavroudis P, Pillai N, Wang Q, Pouzin C, Greene B, Fretland J
CPT Pharmacometrics Syst Pharmacol. 2022; 11(11):1485-1496.
PMID: 36004727
PMC: 9662198.
DOI: 10.1002/psp4.12857.
Circ_0058792 regulates osteogenic differentiation through miR-181a-5p/Smad7 axis in steroid-induced osteonecrosis of the femoral head.
Han N, Qian F, Niu X, Chen G
Bioengineered. 2022; 13(5):12807-12822.
PMID: 35611880
PMC: 9276051.
DOI: 10.1080/21655979.2022.2074617.